Proposal of New Afrezza National Television Commercial

[caesar]

For what it's worth, the last Afrezza commercial was (even though it supposedly won an award) one of the worst commercial Mannkind could have produced. If and when they produce and run another commercial, it would be nice if they followed the format of the twin (male & female lead) 'DUPIXENT' asthma commercials. The whole time the commercial runs the consumer is being informed. The same approach by Mannkind with the inhaler being used (by the lead) all the while bragging about the lifestyle benefits would go a long way. Why not have two leads in the commercial in some social setting (picnic, whatever) one lead inhaling, while the other shooting up the insulin is staring in disbelief.

Mannkind might have a better mousetrap, but it has to go beyond proof of concept. Informing the public about the technology, lifestyle benefits, health benefits is the company's responsibility and requires understanding the dosing requirements. VDEX nor the myriad of endocrinologist should not be put into the position of informing Mannkind - that is a recipe for failure.

[sportsrancho]

That’s what we all suggested at first. Laura K. and Sam having dinner talking about the advantages.

[slapshot]

For me the key is understanding that Afrezza acts differently than RAAs because it is different (doesnt go though the same modifications to insulin as RAAs so that they can be injected which affects the way that RAAs act) and therefore needs to be used differently.

Maybe before we go with another commercial somebody should provide a state of the art analysis (Vdex white paper?) of RAAs including how they are used with emphasis on the "modifications" to the insulin required for injection and the affects (slow intake and then long tail, etc) due to this and then explaining how Afrezza overcomes these obstacles as it isnt modified like the RAAs since it is not injected but instead uses natural human insulin and because of this acts more like natural human insulin in the body, when dosed correctly prevents / limits blood sugar rise in the first place, fast in, fast out, etc.

Why we got to where we are (endos thinking, protocols with RAAs, etc.) may enable us to understand why Afrezza acts differently and therefore needs to be used differently.

[prcgorman2]

I’m just happy we feel like we’re in a place where we can talk about advertising and meaningful marketing again. Money, time, relief from COVID (or at least fatigued to the point where we apparenlty don’t care anymore).

[lennymnkd]

Jan 29, 2022 11:22:23 GMT -5 cretin11 said:

We don’t have the money for that (even if it were the right time to do it).

If we go it alone with Afrezza.. seems to becoming less likely…